# Clinical Trial to Assess the Safety and Efficacy of Investigational Product in Patients Due to Hypospadias Treatment Failure

> **NCT05093166** · PHASE1,PHASE2 · TERMINATED · sponsor: **Holostem s.r.l.** · enrollment: 1 (actual)

## Conditions studied

- Hypospadias

## Interventions

- **DRUG:** "Ex vivo" expanded autologous human oral epithelium containing stem cells

## Key facts

- **NCT ID:** NCT05093166
- **Lead sponsor:** Holostem s.r.l.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-11-26
- **Primary completion:** 2022-12-12
- **Final completion:** 2022-12-12
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Due to the current re-organization at the Sponsor site
- **Last updated:** 2024-11-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05093166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05093166, "Clinical Trial to Assess the Safety and Efficacy of Investigational Product in Patients Due to Hypospadias Treatment Failure". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT05093166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*